Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study.
Zager JS, Orloff M, Ferrucci PF, Choi J, Eschelman DJ, Glazer ES, Ejaz A, Howard JH, Richtig E, Ochsenreither S, Reddy SA, Lowe MC, Beasley GM, Gesierich A, Bender A, Gschnell M, Dummer R, Rivoire M, Arance A, Fenwick SW, Sacco JJ, Haferkamp S, Weishaupt C, John J, Wheater M, Ottensmeier CH. Zager JS, et al. Among authors: ferrucci pf. Ann Surg Oncol. 2024 Aug;31(8):5340-5351. doi: 10.1245/s10434-024-15293-x. Epub 2024 May 4. Ann Surg Oncol. 2024. PMID: 38704501 Free PMC article. Clinical Trial.
Cancer bio-immunotherapy XVI annual NIBIT-(Italian Network for Tumor Biotherapy) meeting, October 11-13 2018, Milan, Italy.
Bellone M, Brevi A, Bruzzì S, Consonni M, De Santis F, Di Lullo G, Majorini MT, Pastò A, Amadori A, Bregni M, Di Nicola M, Calabrò L, Ferrucci PF, Proietti E, Colombo MP, Russo V. Bellone M, et al. Among authors: ferrucci pf. Cancer Immunol Immunother. 2020 Jun;69(6):1141-1151. doi: 10.1007/s00262-020-02502-1. Epub 2020 Feb 6. Cancer Immunol Immunother. 2020. PMID: 32025818 Free PMC article. No abstract available.
Goals and objectives of the Italian Network for Tumor Biotherapy (NIBIT).
Russo V, Amadori A, Bregni M, Calabrò L, Colombo MP, Di Nicola M, Ferrucci PF, Proietti E, Maio M, Bellone M. Russo V, et al. Among authors: ferrucci pf. Cytokine Growth Factor Rev. 2017 Aug;36:1-3. doi: 10.1016/j.cytogfr.2017.06.004. Epub 2017 Jun 16. Cytokine Growth Factor Rev. 2017. PMID: 28634022
Corrigendum: Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study.
Queirolo P, Dozin B, Morabito A, Banelli B, Piccioli P, Fava C, Leo C, Carosio R, Laurent S, Fontana V, Ferrucci PF, Martinoli C, Cocorocchio E, Battaglia A, Ascierto PA, Capone M, Simeone E, De Galitiis F, Pagani E, Antonini Cappellini GC, Marchetti P, Guida M, Tommasi S, Mandalà M, Merelli B, Quaglino P, Fava P, Guidoboni M, Romani M, Spagnolo F, Pistillo MP. Queirolo P, et al. Among authors: ferrucci pf. Front Immunol. 2018 Mar 2;9:403. doi: 10.3389/fimmu.2018.00403. eCollection 2018. Front Immunol. 2018. PMID: 29531523 Free PMC article.
Cancer bio-immunotherapy XVII annual NIBIT (Italian Network for Tumor Biotherapy) meeting, October 11-13 2019, Verona, Italy.
Bellone M, Bregni M, Bronte V, Ugel S, Ferrucci PF, Di Nicola M, Nisticò P, Zuccolotto G, Rosato A, Russo V, Sica A, Colombo MP. Bellone M, et al. Among authors: ferrucci pf. Cancer Immunol Immunother. 2022 Jul;71(7):1777-1786. doi: 10.1007/s00262-021-03104-1. Epub 2021 Nov 9. Cancer Immunol Immunother. 2022. PMID: 34755203 Free PMC article. No abstract available.
Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion.
Conforti F, Pala L, Pagan E, Bagnardi V, De Pas T, Queirolo P, Pennacchioli E, Catania C, Cocorocchio E, Ferrucci PF, Saponara M, Orsolini G, Zagami P, Nicoló E, De Marinis F, Tortora G, Bria E, Minucci S, Joffe H, Veronesi P, Wargo J, Rosenthal R, Swanton C, Mantovani A, Gelber RD, Viale G, Goldhirsch A, Giaccone G. Conforti F, et al. Among authors: ferrucci pf. Clin Cancer Res. 2021 Aug 1;27(15):4311-4324. doi: 10.1158/1078-0432.CCR-21-0136. Epub 2021 May 20. Clin Cancer Res. 2021. PMID: 34016641 Free PMC article.
Differential activity of avapritinib in patients with metastases from mucosal melanoma and thymic carcinoma harbouring KIT exon 17 mutations: Initial experience from a Compassionate Use Program in Italy.
Corti C, Conforti F, Pala L, Catania C, Cocorocchio E, Ferrucci PF, Curigliano G, Queirolo P, de Pas T. Corti C, et al. Among authors: ferrucci pf. Eur J Cancer. 2022 Sep;172:332-339. doi: 10.1016/j.ejca.2022.06.015. Epub 2022 Jul 9. Eur J Cancer. 2022. PMID: 35820244
Cancer bio-immunotherapy XVIII annual NIBIT-(Italian network for tumor biotherapy) meeting, October 15-16, 2020.
Bellone M, Brevi A, Bronte V, Dusi S, Ferrucci PF, Nisticò P, Rosato A, Russo V, Sica A, Toietta G, Colombo MP. Bellone M, et al. Among authors: ferrucci pf. Cancer Immunol Immunother. 2022 Jul;71(7):1787-1794. doi: 10.1007/s00262-022-03145-0. Epub 2022 Jan 16. Cancer Immunol Immunother. 2022. PMID: 35034143 Free PMC article. No abstract available.
Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial.
Hodi FS, Chiarion-Sileni V, Gonzalez R, Grob JJ, Rutkowski P, Cowey CL, Lao CD, Schadendorf D, Wagstaff J, Dummer R, Ferrucci PF, Smylie M, Hill A, Hogg D, Marquez-Rodas I, Jiang J, Rizzo J, Larkin J, Wolchok JD. Hodi FS, et al. Among authors: ferrucci pf. Lancet Oncol. 2018 Nov;19(11):1480-1492. doi: 10.1016/S1470-2045(18)30700-9. Epub 2018 Oct 22. Lancet Oncol. 2018. PMID: 30361170 Clinical Trial.
115 results